TY - JOUR T1 - Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD JF - European Respiratory Journal JO - Eur Respir J VL - 42 IS - Suppl 57 SP - P5060 AU - Shinichi Arizono AU - Hiroyuki Taniguchi AU - Yasuhiro Kondoh AU - Tomoki Kimura AU - Kensuke Kataoka AU - Tomoya Ogawa AU - Fumiko Watanabe AU - Jun Hirasawa AU - Kazuyuki Tabira Y1 - 2013/09/01 UR - http://erj.ersjournals.com/content/42/Suppl_57/P5060.abstract N2 - Study objective: Pulmonary rehabilitation (PR) has been reported useful for improving exercise capacity and health status in patients with idiopathic pulmonary fibrosis (IPF). However it is reported PR demonstrated smaller exercise capacity improvements in IPF patients than in COPD patients. The purpose of the present study was to evaluate the effects of PR in IPF patients and compare their responses with COPD patients who underwent an identical PR program.Methods: Twenty-two IPF patients (%VC: 72%) and 34 COPD patients (%FEV1: 45%) were recruited. Subjects completed a 10-week outpatient pulmonary rehabilitation program. Dyspnea (Baseline dyspnea index: BDI), health status (St. George’s Respiratory Questionnaire: SGRQ) and exercise capacity were assessed at baseline and immediately following completion of the PR program. Five kinds of exercise capacity were endurance time by constant load ergometry test, peak work rate and peak VO2 by incremental load ergometry test, the distance of 6 minutes walking test (6MWD) and incremental shuttle walking test (ISWD).Results: Age, BDI, SGRQ and exercise capacity at baseline were no different between the two groups. Significant improvements in BDI and SGRQ were observed in both groups (p < 0.05). Endurance time, peak work rate, 6MWD and ISWD were improved significantly after 10-weeks (p<0.05), whereas peak VO2 was not improved, in both groups. The magnitude of improvement in all outcomes was no difference in IPF and COPD patients.Conclusions: PR in IPF produced improvements in exercise capacity, dyspnea and health status, as well as in COPD patients. ER -